Mastoid antral XXXX ; new treatment modality for reccurent otitis media with effusion and its long term results.

@entity1 @entity5274 @entity102
OBJECTIVES: To evaluate the efficiency of mastoid antral @entity5274 (MAVT) treatment in recurrent/ @entity102 media with effusion (OME). METHODS: 20 OME @entity1 who were unsuccessfully treated with @entity5274 ( @entity5274 ) at least twice, who consented to MAVT and who were followed up at least three years were included in the study group. Control group comprised 10 @entity1 who had the same characteristics and refused to undergo MAVT and underwent @entity5274 placement again. Pre-operative and post-operative otomicroscopic, hearing tests, and CT findings were compared between the groups statistically. RESULTS: MAVT was placed into 24 ears of 20 @entity1 . In the control group, @entity5274 was placed in 13 ears of 10 @entity1 . Postoperatively, in the study group, one tympanic membrane with adhesion and nine membranes with retraction returned to their anatomic positions after MAVT. In the control group, 2 retracted tympanic membranes returned to normal position. There was significant difference between groups in terms of mastoid aeration (P = 0.006). Post-operative pure tone threshold values and mastoid aeration findings were statistically different from preoperative conditions. CONCLUSION: This preliminary study demonstrates that MAVT may be effective in the surgical treatment of recurrent/chronic OME. However, further studies with larger @entity1 series should be carried out.
